Introduction
Neurofibromatosis type 2 (NF2) is an inherited autosomal dominant disorder in which patients typically develop bilateral vestibular schwannomas and other tumors of the central nervous system (CNS) (Martuza and Eldridge, 1988) . The NF2 gene was positionally cloned in 1993 and identified as a tumor suppressor gene found mutated in the germline of NF2 patients as well as in many sporadic tumors, including meningiomas, schwannomas and ependymomas (Rouleau et al., 1993; Trofatter et al., 1993; Twist et al., 1994) . Mice heterozygous for a mutation in Nf2 were created in an effort to model the human disease.
These animals do not develop CNS tumors but rather a range of highly metastatic sarcomas, which have undergone loss of heterozygosity at the Nf2 locus (McClatchey et al., 1998) . Targeted mutation of the mouse Nf2 gene in Schwann cells induces schwannomas (Giovannini et al., 1999 (Giovannini et al., , 2000 .
The Nf2 protein, merlin, is related to the band 4.1 family of membrane-cytoskeletal linkers (Rouleau et al., 1993; Trofatter et al., 1993) . Within this family, merlin is most similar to ezrin, radixin, and moesin (the ERM proteins), which are implicated in cytoskeletal remodeling and formation of membrane ruffles and microvilli (Franck et al., 1993) . Sequence similarity between the ERM proteins and merlin lies primarily in the conserved N-terminal FERM (4.1, ERM) domain. Merlin shares certain properties with the ERM family, including subcellular localization to cortical actin structures and binding to the integral membrane hyaluronic acid receptor CD44 (Sainio et al., 1997; Tsukita et al., 1994) . However, despite some sequence and functional overlap, it is clear that merlin has distinct properties not shared with the ERM proteins.
Similarities between merlin and the ERM proteins suggest that the growth-regulatory capabilities of merlin may be due to effects on cytoskeletal organization and/or function. A number of laboratories have demonstrated that overexpression of wild-type merlin can inhibit cell proliferation, reduce cell motility, and disrupt the actin cytoskeleton during cell adhesion and spreading (Gutmann et al., 1999b; Lutchman and Rouleau, 1995; Sherman et al., 1997) . Studies using a rat schwannoma model system suggest that merlin helps to mediate contact inhibition of growth through interactions with the cytoplasmic tail of CD44 and signals from the extracellular matrix (Morrison et al., 2001) . These studies and the highly metastatic phenotype of tumors in Nf2 +/7 mice suggest a role for merlin in cell-cell and cell-matrix contacts, most likely associated with the processes of cell migration or invasion, and argue that merlin may regulate intracellular pathways important for both proliferation and actin cytoskeleton processes.
In order to elucidate the role of merlin in tumorigenesis, the effects of loss of merlin function both on an organismal level and in tissue culture have been examined. Several groups have attempted to create dominant-negative alleles of merlin by deleting regions of the conserved FERM domain. Giovannini and colleagues created a transgenic mouse with a mutant allele of Nf2 in which exons 2 and 3 are deleted (Giovannini et al., 1999) . This allele shows a dominant effect on Schwann cell proliferation: the presence of one mutant Nf2 allele (without further loss of the wildtype Nf2 allele) promotes tumorigenesis in these transgenic animals. In tissue culture, Koga and colleagues show that nuclear microinjection of a mutant Nf2 cDNA lacking exon 2 sequences alters subcellular localization of merlin and induces loss of adhesion in an SV40-transformed fibroblast cell line (Koga et al., 1998) . Importantly, deletions of exons in the FERM domain of NF2 are found in human NF2 patients and have been associated with early tumor onset and poor prognosis (Ruttledge et al., 1996) .
Significant information regarding Nf2 function has come from studies in Drosophila. LaJeunesse and colleagues have made a dominant-negative allele of Drosophila Merlin (Mer) by deleting (DBB) or substituting alanine (BBA) for a seven amino acid stretch in the FERM domain (designated 'blue box', a region which is completely conserved between fly and mammalian merlin, but not in the ERM proteins) (LaJeunesse et al., 1998) . When these 'blue box' mutants (Mer DBB or Mer BBA ) are overexpressed in the fly wing, the same phenotype is observed as with somatic loss of function of merlin: overproliferation of wing epithelial cells. Functional studies suggest that these alleles interfere directly with the activity of wildtype merlin protein. These findings, combined with those discussed above, suggest that mutations in the FERM domain of merlin may disrupt cell-to-cell or cell-to-matrix interactions resulting in changes in cell proliferation, morphology, and motility.
Following these studies and the identification of the highly conserved 'blue box' region of the Drosophila Merlin FERM domain as potentially critical to its role as a growth suppressor, we studied the equivalent mutant in the context of mammalian Nf2. Expression of a murine 'blue box' mutant cDNA, Nf2 BBA , in NIH3T3 fibroblasts in tissue culture caused complete transformation of the cells resulting in actin cytoskeleton abnormalities, loss of contact inhibition, growth in soft agar and tumor formation in nude mice.
Results

Expression of Nf2
BBA in NIH3T3 cells causes adhesion defects
In order to examine the effects of the BBA mutation (alanine substitution of codons 177 -183 in murine Nf2) in mammalian cell culture, NIH3T3 cells were infected with recombinant retroviruses carrying the wild-type Nf2 cDNA, mutant Nf2 cDNA, or an empty vector as a control. Infected cell populations were designated 3T3-BABE, 3T3-Nf2 WT , and 3T3-Nf2 BBA , for empty-vector control infected, wild-type Nf2 infected, and Nf2 'blue box' mutant (BBA) infected NIH3T3 cells, respectively. After 3 days of selection in puromycin, cell lysates were prepared to assay for merlin overexpression. Both wild-type merlin (Nf2   WT   ) and FERM domain 'blue box' mutant merlin (Nf2 BBA ) were overexpressed compared to endogenous merlin in the empty-vector (BABE) control cells (Figure 1 ). Overexpression levels of merlin in wild-type and mutant infected NIH3T3 cells were 5 -10-fold higher than endogenous merlin levels in vector control cells. Infected NIH3T3 cells were used one passage immediately following selection for all the experiments described below.
NIH3T3 cells expressing Nf2 BBA displayed an extreme deficiency in cell adhesion. Most notably, at high cell densities, these cells would detach from the plate, making any further analysis difficult. To promote the attachment of these cells, fibronectin-coated tissue culture plates were employed. Initial characterization indicated that 3T3-Nf2 BBA cells remained adherent at all cell densities following this treatment. Thus, all infected cells for all described experiments were plated on fibronectin-coated plates.
3T3-Nf2
BBA cells have abnormal shape and a poorly organized actin cytoskeleton Staining with Oregon Green-phalloidin to examine the actin cytoskeleton revealed that 3T3-Nf2 BBA cells had a very poorly organized cytoskeleton when compared to 3T3-BABE and 3T3-Nf2
WT cells, which possessed wellorganized actin stress fibers (Figure 2 ). In addition, as visualized under immunofluorescence and phase light microscopy, 3T3-Nf2 BBA cells were found to have small cell bodies with many protrusions that tended to cross over nearby cells. Even at lower densities, the 3T3-Nf2 BBA cells grew on top of one another.
BBA cells do not cease to divide at confluency Disorganization of the cytoskeleton is often associated with cellular transformation. Therefore, we proceeded WT and 3T3-BABE cells reached a plateau by day six due to contact inhibition, the 3T3-Nf2
BBA cells continued to accumulate beyond this point (Figure 3a ). In the first 3 days of the experiment, the proliferation rate of the 3T3-Nf2
BBA cells was comparable to that of the 3T3-Nf2
WT and 3T3-BABE cells. Yet, as the cell populations became more dense, and the proliferation rate of the 3T3-Nf2 WT and 3T3-BABE cells began to slow, the 3T3-Nf2
BBA cells continued to accumulate at the same rate (days 4 -8). Overall, 3T3-Nf2 BBA cells did not appropriately respond to growth inhibitory cues upon cell-cell contact. Overexpression of wild-type merlin (3T3-Nf2 WT ) resulted in a small, but statistically significant (P50.017), decrease in the proliferation rate of the cells in the second half of the experiment (days 3 -6) in four out of six cell lines tested ( Figure 3a and data not shown). In addition, as shown in Figure  3a , the cells overexpressing wild-type merlin did not plateau at as high a saturation density as the 3T3-BABE cells. These data are consistent with previous data describing a growth-inhibitory effect of merlin overexpression (Lutchman and Rouleau, 1995) .
To further characterize the cell proliferation phenotype, we assayed the cell cycle profile of the infected cells either in log-phase growth or after being left at confluence for several days. Normal cells undergo a G0/G1 cell cycle arrest when they reach confluency due to contact inhibition. 3T3-Nf2
BBA cells did not undergo the expected G0/G1 cell cycle arrest that was observed in the 3T3-Nf2
WT and 3T3-BABE cells ( Figure 3b ). Flow cytometric analysis of 3T3-Nf2 WT and 3T3-BABE cells grown in serum revealed that about 25% of exponentially growing control cells were in the S phase of the cell cycle, whereas under the same conditions, close to 40% of the 3T3-Nf2 BBA cells were in S phase. The proliferation curve demonstrates that all the infected cell populations have the same doubling rate at the time of cell cycle analysis (equivalent to days 1 -2 of the proliferation assay). Therefore, based on the flow cytometric analysis of exponentially growing cells, 3T3-NF2
BBA cells spend proportionately longer in S phase, and, correspondingly, less time in BBA cells even after they had reached a confluent state, confirming that these cells continued to cycle beyond the point that contact inhibition signals arrested the control cells.
Focus formation and anchorage-independent proliferation
On the basis of the assays described above, 3T3-Nf2 BBA cells share many properties with transformed cells. In order to characterize the transformation phenotype further, we examined the behavior of these cells in two common assays for transformation: focus formation on a monolayer of cells and anchorageindependent growth. When compared to control cells, the 3T3-Nf2
BBA cells formed a dense multilayer of cells on the tissue culture dish as demonstrated by Giemsa staining of cells after 2 weeks in culture (data not shown). In order to visualize this phenotype more clearly, we diluted the infected NIH3T3 cells 1 : 100 into uninfected NIH3T3s before plating. Under these conditions, 3T3-Nf2
BBA cells formed distinct foci on top of the confluent monolayer of cells after just 2 weeks in culture, whereas the control cells formed few to no foci in the same assay (Figure 4 ). In addition, infected cells cultured at high cell density were fixed and their nuclei stained with DAPI. Under a fluorescent microscope, 3T3-Nf2 BBA cells exhibited many layers of overlapping nuclei, indicating that these cells were piling up on one another (data not shown). Control cells displayed no nuclear overlap in the cell monolayer.
Transformed cells often possess the ability to grow in anchorage-independent conditions. The ability of cells to adhere to the substratum of a dish can be denied by embedding the cells in soft agar before plating. Transformed cells will proliferate and form colonies of cells in the layer of soft agar, whereas normal cells will not, because they require adhesion to the substratum to proliferate. When 3T3-Nf2 BBA cells were subjected to a soft agar assay, they proliferated in an anchorage-independent manner, efficiently forming colonies in the soft agar matrix ( Figure 5 ). 3T3-BABE and 3T3-Nf2
WT cells did not form colonies when subjected to the same assay.
3T3-Nf2
BBA cells form tumors in nude mice
To further assess the tumorigenicity of 3T3-Nf2 BBA cells, 1610 6 cells from at least three independentlyderived cell lines of each type were injected into the flanks of nude mice and tumor formation was scored 4 weeks post injection (Table 1) . Small tumors were visible at sites injected with 3T3-Nf2
BBA cells as early as 1 week post-injection, whereas no tumors were visualized when 3T3-Nf2
WT and 3T3-BABE cells were injected. 3T3-Nf2 BBA -derived tumors increased in size over the duration of the experiment, until the tumor masses were harvested for histological examination 4 -6 weeks post-injection (data not shown). There was no tumor growth detected at any of the sites injected with 3T3-Nf2
WT or 3T3-BABE cells at the time of sacrifice.
Discussion
We have shown that expression of a FERM domain mutant of Nf2 (Nf2 BBA ) leads to complete transformation of NIH3T3 cells. Abnormalities in the 3T3-Nf2 BBA cells include disruptions of the actin cytoskeleton, cell adhesion defects, loss of contact inhibition of growth, anchorage-independent growth and the ability to form tumors in nude mice. Our studies support the hypothesis that merlin may be important in regulating cell-cell and cell-matrix contacts and argue that merlin may regulate intracellular pathways important for both proliferation and actin cytoskeleton processes.
Our initial characterization of the phenotype of the 3T3-Nf2
BBA cells revealed a severe deficiency in cell adhesion, both on tissue culture dishes and with respect to the ability of the cells to grow under anchorageindependent conditions. Similar cell adhesion defects have been observed by groups expressing merlin mutants and are indicative of disruptions of cell-matrix interactions (Koga et al., 1998; Stokowski and Cox, 2000) . It is well established that cell adhesion is important for normal cell growth of adherent cells; in fact, anchorage-independent growth is a criterion for cellular transformation (Hynes, 1992; Nur et al., 1992) . Microinjection of Nf2 cDNAs into cultured fibroblasts demonstrates that yet other mutations in the FERM BBA transforms NIH3T3 fibroblasts KC Johnson et al domain affect cell adhesion, causing cell detachment (Koga et al., 1998) . These data suggest that FERM domain mutations may affect cell membrane-cytoskeleton signaling, which consequently could disrupt cellmatrix interaction. Thus, merlin may act as a positive regulator of cell-matrix attachment and disruption of this activity may be an initial step in tumorigenesis.
Interestingly, merlin interacts with b1 integrin in Schwann cells and NIH3T3 cells (Obremski et al., 1998; Johnson and Jacks, unpublished data) . Studying the consequence of such an interaction may be important to uncovering the role of merlin in cell adhesion. b1 integrins, like merlin, have been shown to suppress anchorage-independent growth (Giancotti and Ruoslahti, 1990; Tikoo et al., 1994) , and, most interestingly, b1 integrin interactions with the extracellular matrix and cytoskeleton have been implicated as part of a signal transduction complex necessary for Schwann cell myelination (Fernandez-Valle et al., 1994) . Perhaps loss of merlin expression leads to aberrant signaling downstream of b1 integrins resulting in abnormal growth/proliferation of Schwann cells.
The second striking phenotype exhibited by the 3T3-Nf2
BBA cells was a lack of contact inhibition of growth, which suggests that merlin may play an important role in the response to cell-cell contact. Recent work suggests that merlin helps to mediate contact inhibition of growth through interactions with the membrane protein CD44 (Morrison et al., 2001) . In rat schwannoma cells, which exhibit contact inhibition defects, merlin is expressed at very low levels. However, exogenous expression of wild-type merlin, but not a FERM domain point mutant, can partially rescue this phenotype by inhibition of cell division at high density, thereby exerting contact inhibition signals. This data supports a model in which under growth inhibitory conditions (such as confluency) merlin is active, hypophosphorylated, and bound to CD44, where it may participate in downregulating signaling pathways that lead to cellular proliferation. In addition, cultured, patient-derived NF2-deficient Schwann cells exhibit many phenotypes identical to those seen in 3T3-Nf2 BBA cells, including lack of contact inhibition, anchorage-independent growth and increased cell proliferation (Rosenbaum et al., 1998) . Taken together with our results, these data suggest that mutation of Nf2 leads to misregulation of pathways that direct proper responses to growth inhibitory signals, such as cell-cell contact.
Oncogenic Ras alleles and signaling molecules that act both upstream and downstream of Ras are known to transform NIH3T3 cells (reviewed by Vojtek and Der, 1998) . Therefore, efficient transformation of NIH3T3 cells by Nf2
BBA may indicate that wild-type merlin normally acts to negatively regulate specific Ras signaling pathways. Notably, an early study implicates merlin in the reversal of a Ras-induced malignant phenotype in cultured fibroblasts (Tikoo et al., 1994) . Alternatively, the Nf2 BBA allele may stimulate Ras signaling through some other mechanism. Based on our observations, and previous data, the most obvious candidates downstream of Ras for merlin regulation are the Rho GTPase proteins, several of which have been identified as critical regulators of oncogenic Ras transformation (reviewed by Zohn et al., 1998) . The Rho GTPases, including Rho, Rac, and Cdc42, have been implicated in the establishment of cell-cell contacts and cell-matrix interactions, as well as in the regulation of the actin cytoskeleton and transcriptional activation (reviewed by Schmitz et al., 2000) . Interestingly, Nf27/7 schwannoma cells exhibit abnormal membrane ruffling (a process inhibited by expression of dominant-negative Rac) and disorganized stress fibers (which can be blocked by expression of dominantnegative Rho) (Pelton et al., 1998) . In addition, primary mouse embryo fibroblasts lacking Nf2 display increased levels of activated JNK, a known Rac effector (Shaw et al., 2001) . Taken together, data linking loss of merlin function to alterations in the cytoskeleton and cell-cell and cell-matrix interactions support a role for wild-type merlin in regulating Ras signaling, perhaps at the level of the Rho GTPases.
Studies discussed here and elsewhere have demonstrated that in-frame exon deletions in regions of the FERM domain have led to disruptions in normal cellular architecture suggesting that the sequence, and most likely structural, integrity of the FERM domain is critical to the proper functioning of merlin as a tumor suppressor. The crystal structure of moesin reveals that its FERM domain forms a tri-lobed structure that can interact with the tail domain using specific FERM domain residues (Pearson et al., 2000) . An overlay of the merlin sequence on this structure suggests that the BBA mutation may disrupt merlin self-association, as this mutation may affect part of the second lobe of the FERM domain in a region that is hypothesized to be important for intramolecular association with the tail domain. Importantly, recent data strongly support the hypothesis that the closed/ oligomerized, hypophosphorylated form of merlin is the active, growth-suppressive form (Shaw et al., 2001) . In addition, the same amino acid residues needed for self-association are also required for the growth-and motility-suppressing function of merlin (Gutmann et al., 1999a) . Recent structural data suggests that 'blue box' mutations may not affect the overall structure of the merlin FERM domain but may alter physicochemical properties that are important for the function of this region in merlin (Shimizu et al., 2001) . Thus Nf2 BBA may act by inhibiting head-to-tail association of Nf2 BBA itself and/or disrupting normal head-to-tail interactions of endogenous merlin molecules. Alterna- tively, the Nf2 BBA protein might sequester normal merlin-binding partners, while lacking key residues in the N-terminus to couple those proteins to their proper regulatory proteins. While the nature of these sequestered merlin-binding partners is not known, this cell system may be useful in dissecting the pathways normally controlled by merlin.
Prior studies have led to the suggestion that perhaps some mutations in merlin may act in a dominant manner. Loss of cell attachment still occurs when Nf2 deletion mutants are co-expressed with wild-type merlin in fibroblasts (Koga et al., 1998) . In addition, transgenic expression of an Nf2 mutant lacking exons 2 and 3 specifically in the Schwann cells of an Nf2+/+ mouse leads to the development of schwannomas (Giovannini et al., 1999) . Moreover, the tumorigenic activity of this Nf2 mutant allele is dependent upon the number of wild-type Nf2 alleles in vivo, giving support to the hypothesis that such a mutant allele might act in a dominant-negative manner. Finally, there are isolated examples of human schwannomas in which both a fulllength and a truncated form of merlin were found coexpressed (Harwalkar et al., 1998) . Here, we have demonstrated that exogenous expression of the Nf2 BBA allele in the presence of endogenous merlin in NIH3T3 cells leads to aberrant phenotypes predicted from lossof-merlin function. In support of this, the effects observed with overexpression of Nf2 BBA mimic some of the phenotypes of Nf2-deficient fibroblasts, including proliferation to a high saturation density, presumably due to lack of contact inhibition (Shaw et al., 2001 ).
Although we have not confirmed that Nf2 BBA acts as a dominant-negative allele in the context of murine merlin, our data showing similar phenotypes to those observed in Nf2-deficient fibroblasts and NF2-deficient Schwann cells strongly support this hypothesis. If Nf2
BBA is acting as a dominant-negative protein in fibroblasts, as has been observed with the equivalent mutant in Drosophila, our results confirm the notion that wild-type merlin function is required for proper mediation of cell-cell and cell-matrix interaction.
Addition of Nf2
BBA to NIH3T3 cells may cause disruption of the complexes required for the molecular switch that specifies growth arrest upon cell-cell contact, thereby leading to constant stimulatory signals for proliferation beyond confluency. Confirmation of the putative dominant-negative effects of the NF2 BBA allele could be carried out by 'knocking down' endogenous expression of merlin in wild-type NIH3T3 cells using stable suppression of gene expression by RNAi. Using such cells, and employing the transformation assays described here, the phenotype of loss of merlin expression in NIH3T3 cells could be ascertained and compared to that of the 3T3-Nf2 BBA cells. Finally, a recent study conducted by Stokowski and Cox investigating the phenotype of cultured epithelial cells following introduction of mutant NF2 alleles revealed that a human homologue of the Drosophila Mer DBB (deletion of the 'blue box' region) caused no adhesion defects (Stokowski and Cox, 2000) . This human NF2
DBB allele exhibited near wild-type behavior in most assays, including solubility and self-association. In contrast, the NF2 DBB protein had a slightly altered subcellular localization, and cells expressing this mutant had a mild change in cell shape. Given that both the DBB and BBA alleles behaved identically when expressed in Drosophila, one may have expected similar results in a mammalian context. Perhaps the inconsistencies are due to cell-type or expression-level differences between our experiments and those of Stokowski and Cox. It is also possible that deletion versus alanine substitution in this region may lead to different changes in the mammalian proteins (perhaps due to folding) that ultimately affect their functions in the cell.
In conclusion, we have provided further evidence supporting a role for merlin in tumor suppression. We have shown that expression of a FERM domain mutant of merlin is sufficient to transform established murine fibroblasts in culture. Expression of mutant merlin was associated with actin cytoskeletal abnormalities, lack of contact inhibition, and adhesion defects including anchorage-independent growth. These observations support a broader role for merlin in regulating cell-cell and cell-matrix signals, an area that deserves further investigation. Activation of such signaling pathways due to loss of merlin function may contribute to tumorigenicity in NF2 patients.
Materials and methods
Plasmids
The Nf2 BBA mutant was created by site-directed mutagenesis of wild-type isoform I Nf2 cDNA (Nf2 WT ) in pcDNA3. The Nf2 BBA cDNA was sequenced to verify the presence of the introduced mutations. Nf2
WT and Nf2 BBA cDNAs were amplified with primers that added a 5' BamHI site and a 3' EcoRI site and then cloned into the pBABE-puro retroviral vector.
Retroviral transduction
NIH3T3 cells (ATCC) were infected with high-titer retrovirus stocks produced by transient transfection of FNX cells (gift from G Nolan, UCSF). The efficiency of infection was always 490% (data not shown). The day before infection, NIH3T3 cells were plated at 10 6 cells per 10-cm dish. Infected NIH3T3s were selected for 3 days with 2 mg/ml puromycin (Sigma) and replated for the corresponding assays.
Tissue culture conditions
Dishes and wells were rinsed once with phosphate buffered saline (PBS), and then coated with 10 mg/ml fibronectin in PBS overnight at 48C. Plates were rinsed twice with PBS following coating and blocked with 10% calf serum (10% CS; Sigma) in DME for 1 h at 378C before plating cells. All infected cells were maintained in 10% CS, 5 mM glutamine, and penicillin/streptomycin at 378C in 5% CO 2 .
Immunoblotting
Whole cell extracts of exponentially growing cells were prepared in RIPA lysis buffer (50 mM TRIS-HCl, pH 7.5, 1% Nonidet P-40, 0.25% sodium deoxycholate, 150 mM NaCl, 1 mM EGTA, 1 mM sodium orthovanadate, and 1 mM NaF) containing complete protease inhibitor tablets (Roche). Protein concentrations were determined using the BCA protein assay reagent (Pierce). Immunoblot analysis for merlin was performed using the merlin sc331 antibody (Santa Cruz, 1 : 1000). Actin (sc-1616; Santa Cruz, 1 : 2000) was used as a loading control.
Immunofluorescence
Cells plated on glass coverslips were fixed in 4% paraformaldehyde and permeabilized with 0.5% NP-40. Filamentous actin was observed on a Zeiss microscope following staining with Oregon Green 455-phalloidin (Molecular Probes, 1 : 500). Nuclei were visualized by DAPI staining (0.5 mg/ml).
Proliferation curves
Proliferation rate, as described here, is a measurement of cell accumulation over time and, therefore, does not take into account cell death. Proliferation curves were generated by plating 5610 4 cells into each well of fibronectin-coated 12-well plates then trypsinizing and counting cells every 24 h over an 8 day period. The cells were counted using a Coulter counter (Z1 series, Beckman Coulter). Measurement of cell proliferation was performed in triplicate for each cell line. Cells were fed every 3 days throughout the assay. Statistical analysis was performed using the Student's t-test.
Cell cycle analysis 10 6 cells were plated on 10-cm plates and harvested 1 or 6 days post-plating. Cells at day one represent exponentially growing cells. Those at day six had been confluent for *3 days. Cells were harvested by trypsinization, fixed in 70% ethanol (7208C, overnight), and rehydrated washed with PBS. Samples were incubated at 378C for 30 min with 0.2 mg/ml propidium iodide (Sigma) and 0.1 mg/ml Rnase A (Sigma). After 12 h at 48C, samples were processed by a FACScan (Becton Dickinson) and analysed using ModFit LT Software (Becton Dickinson).
Focus formation assays
Infected NIH3T3 cells were seeded either alone or with uninfected NIH3T3 cells in fibronectin-coated 6-cm dishes at a ratio 1 : 100. Media was changed every 3 days, and the cultures were followed for 3 weeks. Visualization of cells was done with Giemsa (Sigma).
Soft agar assays
25 000 cells were resuspended in 0.34% low melting point agarose (LMP; Gibco -BRL) in DME/HEPES supplemented with 15% CS, penicillin/streptomycin and 5 mM glutamine. Cells were plated onto 6-cm dishes coated with 0.5% LMP agarose in DME. Cultures were maintained at 378C and were supplemented with 2 ml of 0.34% LMP agarose in DME containing 15% CS once a week. Colony formation was followed for 3 weeks.
Tumorigenicity assays
Infected NIH3T3 cells were trypsinized, washed with PBS, and resuspended at 10 7 cells per ml in PBS. 10 6 cells (100 ml) were injected subcutaneously into the flanks of 5 week-old nude mice (BALB/c nu/nu, Jackson Laboratories). Mice were monitored for 6 weeks following injection. At this time, the mice were sacrificed and the tumors resected for histological examination.
